1,551
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Antiresorptive treatment and talar collapse after displaced fractures of the talar neck: a long-term follow-up of 19 patients

, , &

  • Abrahamsen B. Adverse effects of bisphosphonates. Calcif Tissue Int 2010; 86(6): 421–35.
  • Agarwala S, Vijayvargiya M. Bisphosphonate combination therapy for non-femoral avascular necrosis. J Orthop Surg Res 2019; 14(1): 112.
  • Agarwala S, Shah S, Joshi V R. The use of alendronate in the treatment of avascular necrosis of the femoral head. J Bone Joint Surg Br 2009; 91-B(8): 1013–8.
  • Annappa R, Jhamaria N L, Dinesh K V, Devkant, Ramesh R H, Suresh P K. Functional and radiological outcomes of operative management of displaced talar neck fractures. Foot (Edinb) 2015; 25(3): 127–30.
  • Chen C H, Chang J K, Lai K A, Hou S M, Chang C H, Wang G J. Alendronate in the prevention of collapse of the femoral head in nontraumatic osteonecrosis: a two-year multicenter, prospective, randomized, double-blind, placebo-controlled study. Arthritis Rheum 2012; 64(5): 1572–8.
  • Cöster M, Karlsson M K, Nilsson J A, Carlsson A. Validity, reliability, and responsiveness of a self-reported foot and ankle score (SEFAS). Acta Orthop 2012; 83(2): 197–203.
  • Cöster M C, Nilsdotter A, Brudin L, Bremander A. Minimally important change, measurement error, and responsiveness for the Self-Reported Foot and Ankle Score. Acta Orthop 2017; 88(3): 300–4.
  • Dodd A, Lefaivre K A. Outcomes of talar neck fractures: a systematic review and meta-analysis. J Orthop Trauma 2015; 29(5): 210–5.
  • Glimcher M J, Kenzora J E. The biology of osteonecrosis of the human femoral head and its clinical implications, II: The pathological changes in the femoral head as an organ and in the hip joint. Clin Orthop Relat Res 1979; (139): 283–312.
  • Halvorson J J, Winter S B, Teasdall R D, Scott A T. Talar neck fractures: a systematic review of the literature. J Foot Ankle Surg 2013; 52(1): 56–61.
  • Hofstaetter J G, Wang J, Yan J, Glimcher M J. Changes in bone microarchitecture and bone mineral density following experimental osteonecrosis of the hip in rabbits. Cells Tissues Organs 2006; 184(3-4): 138–47.
  • Hosman A H, Mason R B, Hobbs T, Rothwell A G. A New Zealand national joint registry review of 202 total ankle replacements followed for up to 6 years. Acta Orthop 2007; 78(5): 584–91.
  • Lai K-A, Shen W-J, Yang C-Y, Shao C-J, Hsu J-T, Lin R-M. The use of alendronate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis: a randomized clinical study. J Bone Joint Surg 2005; 87(10): 2155–9.
  • Lee Y K, Ha Y C, Cho Y J, Suh K T, Kim S Y, Won Y Y, Min B W, Yoon T R, Kim H J, Koo K H. Does zoledronate prevent femoral head collapse from osteonecrosis? A prospective, randomized, open-label, multicenter study. J Bone Joint Surg Am 2015; 97(14): 1142–8.
  • Li Y T, Cai H F, Zhang Z L. Timing of the initiation of bisphosphonates after surgery for fracture healing: a systematic review and meta-analysis of randomized controlled trials. Osteoporos Int 2015; 26(2): 431–41.
  • Luo R B, Lin T, Zhong H M, Yan S G, Wang J A. Evidence for using alendronate to treat adult avascular necrosis of the femoral head: a systematic review. Med Sci Monit 2014; 20: 2439–47.
  • Nishii T, Sugano N, Miki H, Hashimoto J, Yoshikawa H. Does alendronate prevent collapse in osteonecrosis of the femoral head? Clin Orthop Relat Res 2006; 443: 273–9.
  • Vallier H A, Reichard S G, Boyd A J, Moore T A. A new look at the Hawkins classification for talar neck fractures: which features of injury and treatment are predictive of osteonecrosis? J Bone Joint Surg Am 2014; 96(3): 192–7.
  • Young M L, Little D G, Kim H K. Evidence for using bisphosphonate to treat Legg-Calvé-Perthes disease. Clin Orthop Relat Res 2012; 470(9): 2462–75.